Drug Trial Radar · NCT03910088
Pregabalin Versus Hydrocortisone for Postdural Puncture Headache After Spinal for Cesarean
Last checked: Nov 20, 2026Latest source record: Nov 12, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
30
Actual
Start
Apr 20, 2019
Primary completion
Jun 30, 2019
Study completion Jun 30, 2019
Sponsor
- Lead sponsor
- Cairo UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Apr 10, 2019
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Female only, from 18 years, up to 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Postdural puncture headache (PDPH) is a common complication after spinal anesthesia. The role of pregabalin and hydrocortisone in the treatment of PDPH is unclear. The aim of this work is to assess and compare the efficacy of both drugs in severe cases of PDPH after spinal anesthesia for elective cesarean section.
Conditions
- Post-Dural Puncture Headache
Interventions
Pregabalin 100Mg Oral CapDrug
giving a drug to relieve post-dural puncture headache
HydrocortisoneDrug
Giving drug to relieve post-dural puncture headache
AcetaminophenDrug
giving a drug to relieve post-dural puncture headache
oral fluidsOther
giving oral fluids to maintain good hydration
CaffeineDrug
giving a drug to relieve post-dural puncture headache
DiclofenacDrug
giving a drug to relieve post-dural puncture headache
Primary outcomes
What the sponsor says the trial is designed to measure.
- Assessment of pain using Visual Analogue ScaleTime frame: the first 48 hours following treatment
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Cairo University
Cairo, Zamalek, Egypt
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.